JP2024500313A5 - - Google Patents

Info

Publication number
JP2024500313A5
JP2024500313A5 JP2023534101A JP2023534101A JP2024500313A5 JP 2024500313 A5 JP2024500313 A5 JP 2024500313A5 JP 2023534101 A JP2023534101 A JP 2023534101A JP 2023534101 A JP2023534101 A JP 2023534101A JP 2024500313 A5 JP2024500313 A5 JP 2024500313A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
variable region
chain variable
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534101A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/072723 external-priority patent/WO2022120375A1/en
Publication of JP2024500313A publication Critical patent/JP2024500313A/ja
Publication of JP2024500313A5 publication Critical patent/JP2024500313A5/ja
Pending legal-status Critical Current

Links

JP2023534101A 2020-12-04 2021-12-03 コロナウイルス感染の検出および治療のためのポリペプチド Pending JP2024500313A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063121384P 2020-12-04 2020-12-04
US63/121,384 2020-12-04
PCT/US2021/072723 WO2022120375A1 (en) 2020-12-04 2021-12-03 Polypeptides for detection and treatment of coronavirus infection

Publications (2)

Publication Number Publication Date
JP2024500313A JP2024500313A (ja) 2024-01-09
JP2024500313A5 true JP2024500313A5 (cg-RX-API-DMAC7.html) 2024-12-06

Family

ID=81853577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534101A Pending JP2024500313A (ja) 2020-12-04 2021-12-03 コロナウイルス感染の検出および治療のためのポリペプチド

Country Status (4)

Country Link
US (1) US20240002477A1 (cg-RX-API-DMAC7.html)
EP (1) EP4255487A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024500313A (cg-RX-API-DMAC7.html)
WO (1) WO2022120375A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039597B2 (en) * 2007-09-07 2011-10-18 Agensys, Inc. Antibodies and related molecules that bind to 24P4C12 proteins
UA109888C2 (uk) * 2009-12-07 2015-10-26 ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
WO2013059524A2 (en) * 2011-10-18 2013-04-25 Emory University Antibodies directed against influenza
MY199468A (en) * 2016-09-23 2023-10-31 Regeneron Pharma Anti-steap2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind steap2 and cd3, and uses thereof
KR20250107297A (ko) * 2020-04-02 2025-07-11 리제너론 파아마슈티컬스, 인크. 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편

Similar Documents

Publication Publication Date Title
CN112585165B (zh) 优化的抗tl1a抗体
JP2021526022A5 (cg-RX-API-DMAC7.html)
CN104936981B (zh) Il‑17a结合物及其用途
WO2019062832A1 (zh) Tigit抗体、其抗原结合片段及医药用途
CN119552248A (zh) B7-h4抗体及其使用方法
RU2020130795A (ru) Нейтрализующие антитела к env вич-1 и их применение
CN106565840B (zh) 抗乙肝表面抗原的抗体及其用途
JP2022122865A5 (cg-RX-API-DMAC7.html)
CN105745225A (zh) Nav1.7抗体和使用所述抗体的方法
CN114829395A (zh) 抗angptl3抗体及其应用
CN113840836B (zh) 抗结缔组织生长因子抗体及其应用
CN110461874B (zh) 抗gitr抗体、其抗原结合片段及其医药用途
CN118165106A (zh) 抗犬il-31单克隆抗体及其应用
CN114957468A (zh) 一种抗Siglec15抗体及其用途
TW202309076A (zh) 用於治療α-突觸核蛋白病之抗體
CN112969715B (zh) 一种抗cd47抗原结合蛋白及其应用
JP2024500313A5 (cg-RX-API-DMAC7.html)
CN118667002A (zh) 抗cd27单克隆抗体及其应用
JP2024536358A5 (cg-RX-API-DMAC7.html)
JP2023554347A5 (cg-RX-API-DMAC7.html)
WO2024088342A1 (en) Antibodies against cd24 and uses thereof
CN116284406B (zh) 一种pd-1结合蛋白及其应用
US20250353928A1 (en) Antibodies and antibody fragments that bind ige
WO2025248815A1 (ja) 抗体又はその断片、及び抗インフルエンザワクチン
KR20250005309A (ko) 인터루킨-19를 표적으로 삼는 항체 및 표적 방법